And I'm also pretty sure that the proposed one piece TAVR that...

And I'm also pretty sure that the proposed one piece TAVR that Admedus has developed would be hard to beat in terms of procedure time and costs. If it can be shown to work as well as current offerings.

So Star Bright could be on to a real winner. That's why they are supporting the company, IMO.

It would make far more sense to do some real research into the topic and have a robust and interesting discussion instead of the usual fare of:

"WP stinks",
"the company is going into administration soon",
"I lost all my money investing in Biotechs like Admedus"
and other repetitive variations (usually from non holders...)